AURINIA PHARMACEUTICALS INC. REGISTERED SHARES O.N

WKN
A1W7D4
ISIN
CA05156V1022
  • Equities
  • Equities international
An error occured while loading the chart data.

5.933 EUR Sell

6.249 EUR Buy

-0.06 abs.

-0.9 % rel.

2019-01-23 09:43 amLang & Schwarz
  • Close / Open 6.148 / 6.073
  • High / Low (1 day) 6.100 / 6.073
  • High / Low (1 Year) 6.955 / 3.800
  • 1 Week -8.8 %
  • 1 Month +23.9 %
  • 1 Year +24.9 %

Selected Top-Trade

There are no top-trades for this security.

Popularity indicator

An error occured while loading the chart data.

Trading sentiment

An error occured while loading the chart data.

Latest Comments

Akzidens Hedged Biotech Gems
Catalysts: 2H 2018 12/31/2018 Phase 2 trial to be initiated 2Q 2018 with data due 2H 2018 for dry eye syndrome. 2H 2018 12/31/2018 Phase 2 trial to be initiated 1H 2018. Interim data readouts are anticipated 2H 2018 for Focal segmental glomerulosclerosis (FSGS) and minimal change disease (MCD)
show more
Akzidens Hedged Biotech Gems
Aurinia ist ein klassisches "one trick pony". Das Unternehmen hat aktuell drei klinischen Studien mit ihrem Produktkandidaten Voclosporin und zwar fuer Lupus Nephritis (LN) (Ph III), Nephrotic Syndrome (Ph I) und Dry Eye Syndrome (Ph I).
show more
Don't miss out on anything!
To see all comments of this underlying please create an account.